|
|
Dysregulation of β-catenin by hepatitis
B virus X protein in HBV-infected human hepatocellular carcinomas |
Lei CHEN1,Liang HU1,Liang LI1,Yuan LIU1,Qian-Qian TU1, Yan-Xin CHANG1,He-Xin YAN1,Meng-Chao WU2, Hong-Yang WANG3, |
1.International Cooperation
Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Institute,
Second Military Medical University, Shanghai 200438, China; 2.Second Military Medical
University, Shanghai 200438, China; 3.International Cooperation
Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Institute,
Second Military Medical University, Shanghai 200438, China;National Laboratory
for Oncogenes and Related Genes, Key Lab of Cancer Institute in Renji
Hospital, Shanghai Jiao-Tong University, Shanghai 200441, China; |
|
|
Abstract β-catenin is a key molecule involved in both cell-cell adhesion and Wnt signaling pathway. In our study, we found that, in the development of hepatocellular carcinoma (HCC), β-catenin was correlated with hepatitis B virus (HBV) X gene encoded protein, which is essential for HBV infectivity and is a potential cofactor in viral carcinogenesis. The expression levels of wild-type β-catenin and E-cadherin were decreased in HepG2 cells expressing hepatitis B virus X protein (HBx), accompanied by destabilization of adherens junction. Reverse transcriptase PCR (RT-PCR), Northern and Western blot showed that reduction of wild-type β-catenin expression involved degradation of the protein. However, RNA interference (RNAi) and luciferase assay indicated that HBx enhanced β-catenin mediated signaling in HepG2 cells. In addition, immunohistochemical and Western blot analysis of β-catenin revealed that a decrease in the β-catenin protein level was found in 58.3% of HBV-related HCCs versus 19.2% of non-HBV-related tumors. Our data suggest that the expression of HBx contributed to the development of HCC, in part, by repressing the wild-type β-catenin expression and enforcing β-catenin-dependent signaling pathway, thus inducing cellular changes leading to acquisition of metastatic and/or proliferation properties.
|
Keywords
hepatocellular carcinoma
hepatitis B virus X protein
β-catenin
cell adhesion
E-cadherin
transcriptional activation
|
Issue Date: 05 December 2010
|
|
|
Schafer D F, Sorrell M F. Hepatocellular carcinoma. Lancet, 1999, 353(9160): 1253–1257 PMID: 10217098
|
|
Marchio A, Meddeb M, Pineau P, Danglot G, Tiollais P, Bernheim A, Dejean A. Recurrent chromosomal abnormalities in hepatocellular carcinoma detected bycomparative genomic hybridization. Genes Chromosomes Cancer, 1997, 18(1): 59–65 PMID: 8993981
|
|
Feitelson M A, Duan L X. Hepatitis B virus X antigen in the pathogenesis of chronic infections and thedevelopment of hepatocellular carcinoma. Am J Pathol, 1997, 150(4): 1141–1157 PMID: 9094970
|
|
Su Q, Schr?der C H, Hofmann W J, Otto G, Pichlmayr R, Bannasch P. Expression of hepatitis Bvirus X protein in HBV-infected human livers and hepatocellular carcinomas. Hepatology, 1998, 27(4): 1109–1120 PMID: 9537452
|
|
Kim C M, Koike K, Saito I, Miyamura T, Jay G. HBx gene of hepatitis B virusinduces liver cancer in transgenic mice. Nature, 1991, 351(6324): 317–320 PMID: 2034275
|
|
Slagle B L, Lee T H, Medina D, Finegold M J, Butel J S. Increased sensitivity tothe hepatocarcinogen diethylnitrosamine in transgenic mice carryingthe hepatitis B virus X gene. Mol Carcinog, 1996, 15(4): 261–269 PMID: 8634084
|
|
Terradillos O, Billet O, Renard C A, Levy R, Molina T, Briand P, Buendia M A. The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesisin transgenic mice. Oncogene, 1997, 14(4): 395–404 PMID: 9053836
|
|
Benn J, Schneider R J. Hepatitis B virus HBx protein activates Ras-GTP complex formationand establishes a Ras, Raf, MAP kinase signaling cascade. Proc Natl Acad Sci U S A, 1994, 91(22): 10350–10354 PMID: 7937954
|
|
Natoli G, Avantaggiati M L, Chirillo P, Puri P L, Ianni A, Balsano C, Levrero M. Ras- and Raf-dependent activation of c-jun transcriptional activityby the hepatitis B virus transactivator pX. Oncogene, 1994, 9(10): 2837–2843 PMID: 8084589
|
|
Su F, Schneider R J. Hepatitis B virus HBx protein activates transcription factor NF-kappaBby acting on multiple cytoplasmic inhibitors of rel-related proteins. J Virol, 1996, 70(7): 4558–4566 PMID: 8676482
|
|
Benn J, Su F, Doria M, Schneider R J. Hepatitis B virus HBx protein induces transcription factor AP-1 byactivation of extracellular signal-regulated and c-Jun N-terminalmitogen-activated protein kinases. J Virol, 1996, 70(8): 4978–4985 PMID: 8764004
|
|
Mahé Y, Mukaida N, Kuno K, Akiyama M, Ikeda N, Matsushima K, Murakami S. Hepatitis B virus X protein transactivates human interleukin-8gene through acting on nuclear factor kB and CCAAT/enhancer-bindingprotein-like cis-elements. J Biol Chem, 1991, 266(21): 13759–13763 PMID: 1856209
|
|
Gottlob K, Fulco M, Levrero M, Graessmann A. The hepatitis B virus HBx protein inhibits caspase 3 activity. J Biol Chem, 1998, 273(50): 33347–33353 PMID: 9837909
|
|
Lee T H, Elledge S J, Butel J S. Hepatitis B virus X proteininteracts with a probable cellular DNA repair protein. J Virol, 1995, 69(2): 1107–1114 PMID: 7815490
|
|
Ueda H, Ullrich S J, Gangemi J D, Kappel C A, Ngo L, Feitelson M A, Jay G. Functional inactivation but not structural mutation ofp53 causes liver cancer. Nat Genet, 1995, 9(1): 41–47 PMID: 7704023
|
|
Tlsty T D. Cell-adhesion-dependent influences on genomic instabilityand carcinogenesis. Curr Opin Cell Biol, 1998, 10(5): 647–653 PMID: 9818176
|
|
Kemler R. From cadherins to catenins: cytoplasmic protein interactionsand regulation of cell adhesion. Trends Genet, 1993, 9(9): 317–321 PMID: 8236461
|
|
Kozyraki R, Scoazec J Y, Flejou J F, D'Errico A, Bedossa P, Terris B, Fiorentino M, Bringuier A F, Grigioni W F, Feldmann G. Expression of cadherins and alpha-catenin in primaryepithelial tumors of the liver. Gastroenterology, 1996, 110(4): 1137–1149 PMID: 8613003
|
|
Wei Y, Van Nhieu J T, Prigent S, Srivatanakul P, Tiollais P, Buendia M A. Altered expression of E-cadherinin hepatocellular carcinoma: correlations with genetic alterations,β-catenin expression, and clinical features. Hepatology, 2002, 36(3): 692–701 PMID: 12198663
|
|
Peifer M. β-catenin as oncogene: the smoking gun. Science, 1997, 275(5307): 1752–1753 PMID: 9122680
|
|
Moon R T, Bowerman B, Boutros M, Perrimon N. The promise and perils of Wnt signaling through β-catenin. Science, 2002, 296(5573): 1644–1646 PMID: 12040179
|
|
He T C, Sparks A B, Rago C, Hermeking H, Zawel L, da Costa L T, Morin P J, Vogelstein B, Kinzler K W. Identification of c-MYC as a target of the APC pathway. Science, 1998, 281(5382): 1509–1512 PMID: 9727977
|
|
Tetsu O, McCormick F. β-catenin regulates expression of cyclin D1 in colon carcinomacells. Nature, 1999, 398(6726): 422–426 PMID: 10201372
|
|
Liu C, Li Y, Semenov M, Han C, Baeg G H, Tan Y, Zhang Z, Lin X, He X. Control of β-catenin phosphorylation/degradation by a dual-kinasemechanism. Cell, 2002, 108(6): 837–847 PMID: 11955436
|
|
Bienz M, Clevers H. Linking colorectal cancer to Wnt signaling. Cell, 2000, 103(2): 311–320 PMID: 11057903
|
|
de La Coste A, Romagnolo B, Billuart P, Renard C A, Buendia M A, Soubrane O, Fabre M, Chelly J, Beldjord C, Kahn A, Perret C. Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellularcarcinomas. Proc Natl Acad Sci U S A, 1998, 95(15): 8847–8851 PMID: 9671767
|
|
Samowitz W S, Powers M D, Spirio L N, Nollet F, van Roy F, Slattery M L. β-catenin mutations are more frequent in small colorectaladenomas than in larger adenomas and invasive carcinomas. Cancer Res, 1999, 59(7): 1442–1444 PMID: 10197610
|
|
Laurent-Puig P, Legoix P, Bluteau O, Belghiti J, Franco D, Binot F, Monges G, Thomas G, Bioulac-Sage P, Zucman-Rossi J. Genetic alterations associatedwith hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis. Gastroenterology, 2001, 120(7): 1763–1773 PMID: 11375957
|
|
Hsu H C, Jeng Y M, Mao T L, Chu J S, Lai P L, Peng S Y. β-catenin mutations are associated with a subsetof low-stage hepatocellular carcinoma negative for hepatitis B virusand with favorable prognosis. Am J Pathol, 2000, 157(3): 763–770 PMID: 10980116
|
|
Huang H, Fujii H, Sankila A, Mahler-Araujo B M, Matsuda M, Cathomas G, Ohgaki H. β-catenin mutations are frequent in human hepatocellular carcinomas associatedwith hepatitis C virus infection. Am J Pathol, 1999, 155(6): 1795–1801 PMID: 10595907
|
|
Koch A, Denkhaus D, Albrecht S, Leuschner I, von Schweinitz D, Pietsch T. Childhood hepatoblastomasfrequently carry a mutated degradation targeting box of the β-cateningene. Cancer Res, 1999, 59(2): 269–273 PMID: 9927029
|
|
Lian Z, Liu J, Pan J, Satiroglu Tufan N L, Zhu M, Arbuthnot P, Kew M, Clayton M M, Feitelson M A. A cellular gene up-regulated by hepatitis B virus-encodedX antigen promotes hepatocellular growth and survival. Hepatology, 2001, 34(1): 146–157 PMID: 11431746
|
|
Lian Z, Pan J, Liu J, Zhang S, Zhu M, Arbuthnot P, Kew M, Feitelson M A. The translation initiationfactor, hu-Sui1 may be a target of hepatitisB X antigen in hepatocarcinogenesis. Oncogene, 1999, 18(9): 1677–1687 PMID: 10208429
|
|
Yan H X, He Y Q, Dong H, Zhang P, Zeng J Z, Cao H F, Wu M C, Wang H Y. Physical and functional interaction betweenreceptor-like protein tyrosine phosphatase PCP-2 and β-catenin. Biochemistry, 2002, 41(52): 15854–15860 PMID: 12501215
|
|
Andrews N C, Faller D V. A rapid micropreparation technique for extraction of DNA-binding proteinsfrom limiting numbers of mammalian cells. Nucleic Acids Res, 1991, 19(9): 2499–2506 PMID: 2041787
|
|
Wang H, Lian Z, Lerch M M, Chen Z, Xie W, Ullrich A. Characterization of PCP-2, a novel receptor protein tyrosine phosphatase of the MAM domain family. Oncogene, 1996, 12(12): 2555–2562 PMID: 8700514
|
|
Carruba G, Cervello M, Miceli M D, Farruggio R, Notarbartolo M, Virruso L, Giannitrapani L, Gambino R, Montalto G, Castagnetta L. Truncated form of β-catenin and reduced expressionof wild-type catenins feature HepG2 human liver cancer cells. Ann N Y Acad Sci, 1999, 886: 212–216 PMID: 10667222
|
|
Su Q, Schr?der C H, Hofmann W J, Otto G, Pichlmayr R, Bannasch P. Expression of hepatitis Bvirus X protein in HBV-infected human livers and hepatocellular carcinomas. Hepatology, 1998, 27(4): 1109–1120 PMID: 9537452
|
|
Wang W L, London W T, Feitelson M A. Hepatitis B x antigen in hepatitis B virus carrier patients with liver cancer. Cancer Res, 1991, 51(18): 4971–4977 PMID: 1654208
|
|
Huber A H, Stewart D B, Laurents D V, Nelson W J, Weis W I. The cadherin cytoplasmic domain is unstructured in the absence of β-catenin.A possible mechanism for regulating cadherin turnover. J Biol Chem, 2001, 276(15): 12301–12309 PMID: 11121423
|
|
Polakis P. The oncogenic activation of β-catenin. Curr Opin Genet Dev, 1999, 9(1): 15–21 PMID: 10072352
|
|
Gottardi C J, Wong E, Gumbiner B M. E-cadherin suppresses cellulartransformation by inhibiting β-catenin signaling in an adhesion-independentmanner. J Cell Biol, 2001, 153(5): 1049–1060 PMID: 11381089
|
|
Staal F J, Noort Mv M, Strous G J, Clevers H C. Wnt signals are transmitted through N-terminally dephosphorylatedβ-catenin. EMBO Rep, 2002, 3(1): 63–68 PMID: 11751573
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|